Search
Newrt Medical Completes 800 Million Yuan Series D Financing: 'Radionuclide + Radiopharmaceutical' Drives Independent Control of the Nuclear Medicine Industry Chain
3 day ago /
Read about 0 minute
Author：小编
Chengdu Newrt Medical has completed a Series D financing round of 800 million yuan, advancing the independent preparation of key radionuclides and the clinical translation of innovative radiopharmaceuticals. It has established a research and development platform for 'scarce radionuclides + innovative radiopharmaceuticals' to accelerate the global commercialization process.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
